THERA NEUROPHARMA
Thera is a biotechnology company dedicated to the discovery, development and commercialization of impactful therapeutic interventions for neurodegenerative disorders. Our regenerative molecules and RNA-based compounds are therapeutics potentially disease-modifying for a fatal disease, Amyotrophic Lateral Sclerosis (ALS), and a severely disabling condition, Traumatic Brain Injury (TBI).
THERA NEUROPHARMA
Industry:
Biotechnology
Address:
Berwyn, Pennsylvania, United States
Country:
United States
Website Url:
http://www.theraneuro.com
Status:
Active
Contact:
610.761.7311
Email Addresses:
[email protected]
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright
Similar Organizations
Hepatera
Hepatera is a biotechnology company.
Official Site Inspections
http://www.theraneuro.com
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Thera Neuropharma"
Thera neuropharma
Competitive Advantage. Thera Neuropharma is advancing an innovative approach that employs two complementary technologies. Our small molecule regenerative therapy (SMRT) and self …See details»
Thera Neuropharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 610.761.7311 Thera is a biotechnology company dedicated to the discovery, development and commercialization of impactful …See details»
LEADERSHIP - Thera NeuroPharma
Mr. Maestre serves as ad interim Chief Executive Officer and Chief Operating Officer of the Company. He is a co-Founder, Board member and Corporate Secretary of the company. He …See details»
Thera Neuropharma Company Profile | Management and …
Www.theraneuro.com . Thera Neuropharma Profile and History. Thera NeuroPharma. Our lead candidates are disease-modifying therapeutics for a fatal disease, Amyotrophic Lateral …See details»
Investors - Thera NeuroPharma
•Growing prevalence of neurodegenerative diseases in elderly population • Orphan drug pricing structure: • market size: $1.1 B for ALS (ww) $3.8 B for TBI (USA) • Increase disease …See details»
Thera Neuropharma - Overview, News & Similar companies
Thera Neuropharma contact info: Phone number: (610) 761-7311 Website: www.theraneuro.com What does Thera Neuropharma do? Thera NeuroPharma. Our lead candidates are disease …See details»
Thera Neuropharma - Craft
Thera Neuropharma has 1 employees at their 1 location. See insights on Thera Neuropharma including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Thera Neuropharma - VentureRadar
"Thera Neuropharma investigates the use of small molecules and RNA-based compounds as therapeutics to treat Amyotrophic Lateral Sclerosis (ALS) and Traumatic Brain Injury (TBI).See details»
Theraneuro - Company Profile - Tracxn
Theraneuro - Developing small molecules that upregulate neuroprotective pathway for the treatment of neurologic disorders, initially focusing on ALS and TBI. Raisedfunding over 1 …See details»
Thera Neuropharma, Inc. - Drug pipelines, Patents, Clinical
Theraneuro.com. Subsidiary Company | Pennsylvania, United States | theraneuro.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational Medicine. Profit. ... The statistics …See details»
Theraneuro | Founders and Board of Directors - Tracxn
List of Founders and Board of members of TheraneuroSee details»
Thera Neuropharma - Wiki - Golden
Thera Neuropharma is a Berwyn, Pennsylvania-based company. Overview Structured Data Issues Contributors Activity. ContentsSee details»
Theraneuro - Raised Funding from 1 investor - Tracxn
Jan 23, 2025 Rich Data Sets. Companies Investors Funding Acquisitions Financials CapTables Investors Funding Acquisitions Financials CapTablesSee details»
The Neuro | Montreal Neurological Institute and Hospital
A global leader in brain research and advanced patient care, the Montreal Neurological Institute and Hospital (The Neuro) conducts 20% of all phase I clinical trials in Canada and recruits …See details»
Technology - Thera NeuroPharma
Technology Platforms. The small molecule regenerative therapy (SMRT) technology uncovers the therapeutic potential of dual-target approach leveraging the direct activation of the nuclear …See details»
The Neuro (Montreal Neurological Institute-Hospital) - LinkedIn
The Conscience Symposium on Open Drug Discovery from April 7-8 in Montreal will provide impactful discussions, panels, and workshops highlighting how Open Science is already …See details»
Alzamend Neuro announces initiation of Phase II trial of AL001
Mar 11, 2025 Alzamend Neuro announced its plans to initiate a highly anticipated phase II clinical study of AL001 for treatment of patients with PTSD in the fourth quarter of 2025.This …See details»
Alzamend Neuro Announces Initiation Date of Phase II Clinical …
1 day ago Alzamend Neuro, Inc. Head-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure …See details»
Research and Development - Thera NeuroPharma
Thera has selected two lead chemical compounds, SYN1 and SYN2, and has already performed preliminary research to characterize their pharmacology, drug distribution, animal efficacy and …See details»
Alzamend Neuro Announces Initiation Date of Phase II Clinical …
1 day ago About Alzamend Neuro . Alzamend Neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s, BD, MDD …See details»